OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MAXI58

MAXI.NS

Life & Health InsuranceVerified

MAXI.NS has a liquidity position that is characterized as medium, with a debt-to-equity ratio of 0.27, indicating a relatively conservative capital structure. The company's free cash flow of 4.26 billion INR and operating cash flow of 83.52 billion INR suggest a strong ability to generate cash from operations. However, the company's net cash is negative after subtracting total debt, which could pose a liquidity risk. In terms of profitability, MAXI.NS has a return on equity (ROE) of 6.2%, which is a measure of how effectively the company uses shareholders' equity to generate profits. The return on assets (ROA) is 0.17%, indicating that the company is not generating significant returns relative to its total assets. These metrics should be compared against the industry medians to assess the company's performance relative to its peers. The company's revenue concentration is not explicitly detailed in the provided data, but as a Life & Health Insurance provider, it is likely that MAXI.NS serves a broad customer base across various geographic regions. The absence of specific segment or geographic data limits the ability to assess the risk associated with revenue concentration. Looking at the growth trajectory, MAXI.NS has demonstrated a positive operating income of 19.14 billion INR and a net income of 3.27 billion INR. The company's capital expenditure of -2.18 billion INR suggests that it is not investing heavily in new projects or infrastructure, which could indicate a focus on maintaining current operations rather than expansion. The outlook for the company's revenue and profitability will depend on its ability to manage costs and maintain or grow its customer base. The risk assessment for MAXI.NS indicates a low potential for dilution, which is a positive sign for shareholders. However, the company's liquidity risk is rated as medium, which could affect its ability to meet short-term obligations. The dilution risk is further supported by the fact that the number of shares outstanding for both basic and diluted shares is the same, suggesting no imminent threat of share dilution. Recent events and filings have not been provided in the input data, so it is not possible to comment on any specific recent developments that may have impacted MAXI.NS. The company's performance and strategic direction will be influenced by its ability to adapt to market conditions and regulatory changes in the insurance industry.

30-day price · MAXI-17.20 (-1.0%)
Low$1560.00High$1748.00Close$1682.30As of27 May, 00:00 UTC
Profile
CompanyMAXI.NS
TickerMAXI.NS
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. MAXI.NS operates in the Life & Health Insurance industry, providing insurance products and services to customers, generating revenue primarily through premium income and investment returns.

Classification. MAXI.NS is classified under the Financials economic sector, Insurance business sector, and Life & Health Insurance industry with a confidence level of 0.92.

MAXI.NS has a liquidity position that is characterized as medium, with a debt-to-equity ratio of 0.27, indicating a relatively conservative capital structure. The company's free cash flow of 4.26 billion INR and operating cash flow of 83.52 billion INR suggest a strong ability to generate cash from operations. However, the company's net cash is negative after subtracting total debt, which could pose a liquidity risk. In terms of profitability, MAXI.NS has a return on equity (ROE) of 6.2%, which is a measure of how effectively the company uses shareholders' equity to generate profits. The return on assets (ROA) is 0.17%, indicating that the company is not generating significant returns relative to its total assets. These metrics should be compared against the industry medians to assess the company's performance relative to its peers. The company's revenue concentration is not explicitly detailed in the provided data, but as a Life & Health Insurance provider, it is likely that MAXI.NS serves a broad customer base across various geographic regions. The absence of specific segment or geographic data limits the ability to assess the risk associated with revenue concentration. Looking at the growth trajectory, MAXI.NS has demonstrated a positive operating income of 19.14 billion INR and a net income of 3.27 billion INR. The company's capital expenditure of -2.18 billion INR suggests that it is not investing heavily in new projects or infrastructure, which could indicate a focus on maintaining current operations rather than expansion. The outlook for the company's revenue and profitability will depend on its ability to manage costs and maintain or grow its customer base. The risk assessment for MAXI.NS indicates a low potential for dilution, which is a positive sign for shareholders. However, the company's liquidity risk is rated as medium, which could affect its ability to meet short-term obligations. The dilution risk is further supported by the fact that the number of shares outstanding for both basic and diluted shares is the same, suggesting no imminent threat of share dilution. Recent events and filings have not been provided in the input data, so it is not possible to comment on any specific recent developments that may have impacted MAXI.NS. The company's performance and strategic direction will be influenced by its ability to adapt to market conditions and regulatory changes in the insurance industry.
Key takeaways
  • MAXI.NS has a medium liquidity risk, with a debt-to-equity ratio of 0.27 and a negative net cash position after subtracting total debt.
  • The company's return on equity is 6.2%, which is a positive indicator of profitability, but its return on assets is low at 0.17%.
  • The company's capital expenditure is negative, indicating a lack of investment in new projects or infrastructure.
  • The risk of dilution is low, as the number of shares outstanding for both basic and diluted shares is the same.
  • The company's growth trajectory will depend on its ability to manage costs and maintain or grow its customer base.
  • # RATIONALES
  • margin_outlook_rationale: The company's operating margin is expected to remain stable, driven by its ability to generate consistent operating income.
  • rd_outlook_rationale: There is no specific information provided on the company's research and development activities.
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income$19.14B
Net income$3.27B
R&D
SG&A
D&A
SBC
Operating cash flow$83.52B
CapEx-$2.18B
Free cash flow$4.26B
Total assets$1.90T
Total liabilities$1.85T
Total equity$52.75B
Cash & equivalents$1.00B
Long-term debt$14.37B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$52.75B
Net cash-$13.37B
Current ratio
Debt/Equity0.3
ROA0.2%
ROE6.2%
Cash conversion25.5%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricMAXIActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity27.0%27.5% medp25 4.7% · p75 66.5%below median
Observations
IR observations
Mean price target2,043.81 INR
Median price target2,040.00 INR
High price target2,675.00 INR
Low price target1,750.00 INR
Mean recommendation1.62 (1=strong buy, 5=strong sell)
Strong-buy count10.00
Buy count16.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate10.81 INR
Last actual EPS9.53 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 19:12 UTC#a8e81b02
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 12:28 UTCJob: 5e014426